A prospective study found PSMA PET/CT-targeted biopsy detected more clinically significant prostate cancer than systematic biopsy in men with nondiagnostic MRI.
Energy savings in CT and MRI can come from low-power modes, protocol optimization, and better measurement, with medical physicists helping integrate changes into clinical workflows.
Midea Group has expanded its presence in the medical technology sector with the acquisition of a controlling stake in Italian medical imaging company Esaote, bringing the company into its Healthcare Division.
Brainomix reports Phase III INBUILD data on quantitative CT in 474 patients with progressive pulmonary fibrosis, examining treatment response and FVC decline.
USC researchers are developing a miniaturized PET radiotracer platform designed to simplify production, accelerate tracer development and expand molecular imaging applications.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.
